幹細胞の世界市場:市場規模、シェア、動向分析(2020-2027)

Grand View Researchが発行した調査報告書(GVR20MA126)
◆英語タイトル:Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, HESC), By Application, By Technology, By Therapy, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GVR20MA126
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年2月
◆ページ数:190
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、幹細胞の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場の要因・動向・範囲、製品別(成人幹細胞、HESC、IPS細胞)分析、用途別(再生医療、医薬品発見及び開発)分析、技術別(細胞取得、細胞生産、凍結保存、拡張およびサブカルチャー)分析、治療別(自家幹細胞療法、同種幹細胞療法)分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法
・エグゼクティブサマリー
・市場の要因・動向・範囲
・幹細胞の世界市場:製品別(成人幹細胞、HESC、IPS細胞)
・幹細胞の世界市場:用途別(再生医療、医薬品発見及び開発)
・幹細胞の世界市場:技術別(細胞取得、細胞生産、凍結保存、拡張およびサブカルチャー)
・幹細胞の世界市場:治療別(自家幹細胞療法、同種幹細胞療法)
・幹細胞の世界市場:地域別
・競争状況
【レポートの概要】

The global stem cells market size is expected to reach USD 17.9 billion by 2027, expanding at a CAGR of 8.2%, according to a new report by Grand View Research, Inc. Recent advances in tissue engineering strategies hold the potential to draw attention to the treatment of several chronic disorders. Moreover, automation in adult and cord blood processing and storage is expected to drive market growth significantly.

The development of banking facilities and resultant enhancement of stem cell production, storage, and characterization are also expected to enhance the volumetric capabilities of this therapy, globally. This would lead to revenue generation in the global market.

Regenerative medicine and cellular therapies are considered to transform the healthcare industry in a few years. Therefore, key players are focused on developing advanced therapeutics for the treatment of Alzheimer’s disease, Parkinson’s disease, degenerative eye disorders, cancer, and stroke. Most of these therapies are under clinical trials and are expected to be launched soon.

Furthermore, the presence of a strong, diverse clinical pipeline is expected to accelerate revenue generation in the global market. Easy access to data through genomic, proteomic, and EHR databases has encouraged companies to investigate various therapies to aid in the treatment of previously untreatable conditions.

Further key findings from the report suggest:

• Adult stem cells (ASCs) segment occupied the largest share of the products in 2019 and is expected to maintain its dominance across the analysis period

• Factors such as long term renewal property, low rejection rates, and minimal ethical concerns associated with the utility of ASCs are attributive towards larger market share

• The regenerative medicine segment accounted for the largest share of owing to a huge pipeline for regenerative medicine products

• The cell acquisition technology segment occupied a major revenue share and is anticipated to witness the fastest CAGR over the forecast period owing to a rise in the number of research projects that require the application of cell harvesting technologies

• Allogenic therapy is the most commonly adopted therapy owing to its graft-versus-cancer response in cancer treatment and graft-versus-host response in organ or tissue transplant

• These responses allow allogenic stem cells to kill the cancer remaining after drug therapy and to prevent organ rejection and other complications post-surgery

• Presence of major companies, extensive government funding, and increasing research have contributed to the largest market share in North America

• The Asia Pacific region is expected to grow at a lucrative pace owing to strong product pipelines in regenerative therapies and large patient population

• Osiris Therapeutics Inc; BIOTIME, INC.; Celgene Corporation; STEMCELL Technologies Inc.; and Cynata are some of the key players operating in the stem cells market.

• The key players are undertaking strategic initiatives to maintain their market share. They are keen to seek investment from other bodies and also collaborate with other pharmaceutical giants. This is set to enhance market growth over the forecast period.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 List of Data Sources
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Stem Cells Market Variables, Trends & Scope
3.1 Market Segmentation& Scope
3.1.1 Market Driver Analysis
3.1.1.1 Technological advancement involving stem cells therapy
3.1.1.2 Increasing vaccine production
3.1.1.3 Rising demand for regenerative medicines
3.1.1.4 Patent expiration of blockbuster biologics
3.1.1.5 Rising demand for monoclonal antibodies
3.1.1.6 Growing R&D investments in biotechnology sector
3.1.1.7 Development of effective personalized medicine diagnostic & therapeutic procedures
3.1.1.8 Increasing prevalence of cancer
3.1.2 Market Restraint Analysis
3.1.2.1 Ethical concerns related to stem cell research
3.2 Penetration & Growth Prospect Mapping for Stem Cell Product Types, 2019
3.3 Stem Cells Market & Regenerative Medicine Pipeline Analysis
3.3.1 Pfizer Inc.
3.3.2 Abbott (St. Jude Children’s Research Hospital)
3.3.3 GlaxoSmithKline plc.
3.3.4 Baxter
3.3.5 Stempeutics Research Pvt Ltd
3.3.6 ReNeuron Group plc
3.3.7 Regen BioPharma, Inc
3.3.8 Promethera Biosciences
3.3.9 U.S. Stem cell Inc.
3.3.10 Astellas Pharma Inc.
3.3.11 Stempeutics Research Pvt. Ltd
3.3.12 Pluristem Therapeutics, Inc. (PSTI)
3.4 Stem Cells – SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis – Porter’s
Chapter 4 Stem Cells Market Categorization: Product Estimates & Trend Analysis
4.1 Stem Cells Market: Product Movement Analysis
4.2 Adult stem cells
4.2.1 Global adult stem cells market, 2016 – 2027 (USD Million)
4.2.2 Neuronal stem cells
4.2.2.1 Global neuronal stem cells market, 2016 – 2027 (USD Million)
4.2.3 Hematopoietic stem cells
4.2.3.1 Global hematopoietic stem cells market, 2016 – 2027 (USD Million)
4.2.4 Mesenchymal stem cells
4.2.4.1 Global mesenchymal stem cells market, 2016 – 2027 (USD Million)
4.2.5 Umbilical cord stem cells
4.2.5.1 Global umbilical cord stem cells market, 2016 – 2027 (USD Million)
4.2.6 Dental stem cells
4.2.6.1 Global dental stem cells market, 2016 – 2027 (USD Million)
4.2.7 Adipose‐derived stem cells
4.2.7.1 Global adipose‐derived stem cells market, 2016 – 2027 (USD Million)
4.2.8 Dedifferentiated fat (DFAT) cells
4.2.8.1 Global dedifferentiated fat (DFAT) cells market, 2016 – 2027 (USD Million)
4.2.9 Other adult-derived stem cells
4.2.9.1 Global other adult-derived stem cells market, 2016 – 2027 (USD Million)
4.3 Human embryonic stem cells
4.3.1 Global human embryonic stem cells market, 2016 – 2027 (USD Million)
4.4 IPS cells
4.4.1 Global IPS cells market, 2016 – 2027 (USD Million)
4.5 Very small embryonic like stem cells
4.5.1 Global very small embryonic like stem cells market, 2016 – 2027 (USD Million)
Chapter 5 Stem Cells Market Categorization: Application Estimates & Trend Analysis
5.1 Stem Cells Market: Application Movement Analysis
5.2 Regenerative medicine
5.2.1 Global regenerative medicine market, 2016 – 2027 (USD Million)
5.2.2 Neurology
5.2.2.1 Global neurology-based market, 2016 – 2027 (USD Million)
5.2.3 Orthopedics
5.2.3.1 Global orthopedics market, 2016 – 2027 (USD Million)
5.2.4 Oncology
5.2.4.1 Global oncology-based market, 2016 – 2027 (USD Million)
5.2.5 Hematology stem cells
5.2.5.1 Global hematology stem cells market, 2016 – 2027 (USD Million)
5.2.6 Cardiovascular and myocardial infarction-based
5.2.6.1 Global cardiovascular and myocardial infarction-based market, 2016 – 2027 (USD Million)
5.2.7 Soft tissue injuries
5.2.7.1 Global soft tissue injuries market, 2016 – 2027 (USD Million)
5.2.8 Diabetes
5.2.8.1 Global diabetes market, 2016 – 2027 (USD Million)
5.2.9 Liver disorder
5.2.9.1 Global liver disorder market, 2016 – 2027 (USD Million)
5.2.10 Incontinence
5.2.10.1 Global incontinence market, 2016 – 2027 (USD Million)
5.2.11 Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
5.2.11.1 Global Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder) market, 2016 – 2027 (USD Million)
5.3 Drug discovery & development
5.3.1 Global drug discovery & development market, 2016 – 2027 (USD Million)
Chapter 6 Stem Cells Market Categorization: Technology Estimates & Trend Analysis
6.1 Stem Cells Market: Technology Movement Analysis
6.2 Cell acquisition
6.2.1 Global cell acquisition market, 2016 – 2027 (USD Million)
6.2.2 Bone marrow harvest
6.2.2.1 Global bone marrow harvest market, 2016 – 2027 (USD Million)
6.2.3 Umbilical cord blood
6.2.3.1 Global umbilical cord blood market, 2016 – 2027 (USD Million)
6.2.4 Apheresis
6.2.4.1 Global apheresis market, 2016 – 2027 (USD Million)
6.3 Cell production
6.3.1 Global cell production market, 2016 – 2027 (USD Million)
6.3.2 Therapeutic cloning
6.3.2.1 Global therapeutic cloning market, 2016 – 2027 (USD Million)
6.3.3 In-vitro Fertilization
6.3.3.1 Global In-vitro Fertilization market, 2016 – 2027 (USD Million)
6.3.4 Cell culture
6.3.4.1 Global cell culture market, 2016 – 2027 (USD Million)
6.3.5 Isolation
6.3.5.1 Global isolation market, 2016 – 2027 (USD Million)
6.4 Cryopreservation
6.4.1 Global cryopreservation market, 2016 – 2027 (USD Million)
6.5 Expansion and sub-culture
6.5.1 Global expansion and sub-culture market, 2016 – 2027 (USD Million)
Chapter 7 Stem Cells Market Categorization: Stem Cell Therapy Estimates & Trend Analysis
7.1 Stem Cells Market: Stem Cells Therapy Movement Analysis
7.2 Autologous Stem Cell Therapy
7.2.1 Global autologous stem cell therapy market, 2016 – 2027 (USD Million)
7.3 Allogenic Stem Cell Therapy
7.3.1 Global allogenic stem cell therapy market, 2016 – 2027 (USD Million)
Chapter 8 Stem Cells Market Categorization: Regional Estimates & Trend Analysis, by Service Type, Sector, & Application
8.1 Stem cells market share by region, 2019 & 2027
8.2 North America
8.2.1 North America stem cells market, 2016 – 2027 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. stem cell market, by product 2016 – 2027 (USD Million)
8.2.2.2 U.S. stem cell market, by application 2016 – 2027 (USD Million)
8.2.2.3 U.S. stem cell market, by technology 2016 – 2027 (USD Million)
8.2.2.4 U.S. stem cell market, by therapy 2016 – 2027 (USD Million)
8.2.3 Canada
8.2.3.1 Canada stem cell market, by product 2016 – 2027 (USD Million)
8.2.3.2 Canada stem cell market, by application 2016 – 2027 (USD Million)
8.2.3.3 Canada stem cell market, by technology 2016 – 2027 (USD Million)
8.2.3.4 Canada stem cell market, by therapy 2016 – 2027 (USD Million)
8.3 Europe
8.3.1 Europe stem cells market, 2016 – 2027 (USD Million)
8.3.2 Germany
8.3.2.1 Germany stem cell market, by product 2016 – 2027 (USD Million)
8.3.2.2 Germany stem cell market, by application 2016 – 2027 (USD Million)
8.3.2.3 Germany stem cell market, by technology 2016 – 2027 (USD Million)
8.3.2.4 Germany stem cell market, by therapy 2016 – 2027 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. stem cell market, by product 2016 – 2027 (USD Million)
8.3.3.2 U.K. stem cell market, by application 2016 – 2027 (USD Million)
8.3.3.3 U.K. stem cell market, by technology 2016 – 2027 (USD Million)
8.3.3.4 U.K. stem cell market, by therapy 2016 – 2027 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific stem cells market, 2016 – 2027 (USD Million)
8.4.2 Japan
8.4.2.1 Japan stem cell market, by product 2016 – 2027 (USD Million)
8.4.2.2 Japan stem cell market, by application 2016 – 2027 (USD Million)
8.4.2.3 Japan stem cell market, by technology 2016 – 2027 (USD Million)
8.4.2.4 Japan stem cell market, by therapy 2016 – 2027 (USD Million)
8.4.3 China
8.4.3.1 China stem cell market, by product 2016 – 2027 (USD Million)
8.4.3.2 China stem cell market, by application 2016 – 2027 (USD Million)
8.4.3.3 China stem cell market, by technology 2016 – 2027 (USD Million)
8.4.3.4 China stem cell market, by therapy 2016 – 2027 (USD Million)
8.5 Latin America
8.5.1 Latin America stem cells market, 2016 – 2027 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil stem cell market, by product 2016 – 2027 (USD Million)
8.5.2.2 Brazil stem cell market, by application 2016 – 2027 (USD Million)
8.5.2.3 Brazil stem cell market, by technology 2016 – 2027 (USD Million)
8.5.2.4 Brazil stem cell market, by therapy 2016 – 2027 (USD Million)
8.6 Middle East & Africa
8.6.1 Middle East & Africa stem cells market, 2016 – 2027 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa stem cell market, by product 2016 – 2027 (USD Million)
8.6.2.2 South Africa stem cell market, by application 2016 – 2027 (USD Million)
8.6.2.3 South Africa stem cell market, by technology 2016 – 2027 (USD Million)
8.6.2.4 South Africa stem cell market, by therapy 2016 – 2027 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participant Categorization
9.3 Company Profiles
9.3.1 Celgene Corporation
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 ReNeuron Group plc
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Virgin Health Bank
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 BIOVAULT FAMILY
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Precious Cells International Ltd
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Mesoblast Ltd
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Caladrius
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Neuralstem, Inc.
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Opexa Therapeutics, Inc.
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Pluristem
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 STEMCELL Technologies Inc.
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 Cesca Therapeutics, Inc.
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 Astellas Pharma, Inc.
9.3.13.1 Company overview
9.3.13.1.1 Ocata Therapeutics, Inc.
9.3.13.2 Financial performance
9.3.13.2.1 Financial performance
9.3.13.3 Product benchmarking
9.3.13.4 Strategic initiatives
9.3.14 Cellular Engineering Technologies
9.3.14.1 Company overview
9.3.14.2 Financial performance
9.3.14.3 Product benchmarking
9.3.14.4 Strategic initiatives
9.3.15 BioTime, Inc.
9.3.15.1 Company overview
9.3.15.1.1 Cell Cure Neurosciences LTD.
9.3.15.1.2 ESI BIO
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 BrainStorm Cell Therapeutics
9.3.16.1 Company overview
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 Vericel Corporation
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
9.3.18 Nuo Therapeutics, Inc.
9.3.18.1 Company overview
9.3.18.1.1 ALDAGEN
9.3.18.2 Financial performance
9.3.18.3 Product benchmarking
9.3.18.4 Strategic initiatives
9.3.19 U.S Stem Cell, Inc.
9.3.19.1 Company overview
9.3.19.2 Financial performance
9.3.19.3 Product benchmarking
9.3.19.4 Strategic initiatives
9.3.20 Athersys, Inc.
9.3.20.1 Company overview
9.3.20.2 Financial performance
9.3.20.3 Product benchmarking
9.3.20.4 Strategic initiatives
9.3.21 Cytori Therapeutics, Inc.
9.3.21.1 Company overview
9.3.21.2 Financial performance
9.3.21.3 Product benchmarking
9.3.21.4 Strategic initiatives
9.3.22 Cryo-Cell International Inc.
9.3.22.1 Company overview
9.3.22.2 Financial performance
9.3.22.3 Product benchmarking
9.3.22.4 Strategic initiatives

List of Tables

TABLE 1 Healthcare expenditure levels, 2012
TABLE 2 Regional cancer prevalence, 2012
TABLE 3 Ongoing clinical trials using MSCs for the treatment of osteoarthritis
TABLE 4 North America stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 5 North America adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 6 North America stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 7 North America regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 8 North America stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 9 North America cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 10 North America cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 11 North America stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 12 U.S. stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 13 U.S. adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 14 U.S. stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 15 U.S. regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 16 U.S. stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 17 U.S. cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 18 U.S. cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 19 U.S. stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 20 Canada stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 21 Canada adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 22 Canada stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 23 Canada regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 24 Canada stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 25 Canada cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 26 Canada cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 27 Canada stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 28 Europe stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 29 Europe adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 30 Europe stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 31 Europe regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 32 Europe stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 33 Europe cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 34 Europe cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 35 Europe stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 36 Germany stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 37 Germany adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 38 Germany stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 39 Germany regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 40 Germany stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 41 Germany cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 42 Germany cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 43 Germany stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 44 U.K. stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 45 U.K. adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 46 U.K. stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 47 U.K. regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 48 U.K. stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 49 U.K. cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 50 U.K. cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 51 U.K. stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 52 Asia Pacific stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 53 Asia Pacific adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 54 Asia Pacific stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 55 Asia Pacific regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 56 Asia Pacific stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 57 Asia Pacific cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 58 Asia Pacific cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 59 Asia Pacific stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 60 Japan stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 61 Japan adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 62 Japan stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 63 Japan regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 64 Japan stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 65 Japan cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 66 Japan cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 67 Japan stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 68 China stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 69 China adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 70 China stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 71 China regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 72 China stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 73 China cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 74 China cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 75 China stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 76 Latin America stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 77 Latin America adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 78 Latin America stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 79 Latin America regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 80 Latin America stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 81 Latin America cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 82 Latin America cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 83 Latin America stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 84 Brazil stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 85 Brazil adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 86 Brazil stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 87 Brazil regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 88 Brazil stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 89 Brazil cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 90 Brazil cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 91 Brazil stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 92 Middle East & Africa stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 93 Middle East & Africa adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 94 Middle East & Africa stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 95 Middle East & Africa regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 96 Middle East & Africa stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 97 Middle East & Africa cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 98 Middle East & Africa cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 99 Middle East & Africa stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 100 South Africa stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 101 South Africa adult stem cells market, by product, 2016 - 2027 (USD Million)
TABLE 102 South Africa stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 103 South Africa regenerative medicine application of stem cells market, by application, 2016 - 2027 (USD Million)
TABLE 104 South Africa stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 105 South Africa cell acquisition stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 106 South Africa cell production stem cells market, by technology, 2016 - 2027 (USD Million)
TABLE 107 South Africa stem cells market, by stem cell type, 2016 - 2027 (USD Million)
TABLE 108 List of cord blood and stem cell partners in Europe & Middle East


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 幹細胞の世界市場:市場規模、シェア、動向分析(2020-2027)(Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, HESC), By Application, By Technology, By Therapy, By Region, And Segment Forecasts, 2020 - 2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆